Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, Single-arm Study of Luvometinib Monotherapy in Pediatric Langerhans Cell Histiocytosis With Single-system Special-site Single and Multifocal Bone Involvement

NCT07371182 is registered in ClinicalTrials.gov with West China Second University Hospital as lead sponsor.

NCT NCT07371182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07371182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, Single-arm Study of Luvometinib Monotherapy in Pediatric Langerhans Cell Histiocytosis With Single-system Special-site Single and Multifocal Bone Involvement
Lead sponsor
West China Second University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 19, 2026
Completion date
December 31, 2030
Enrollment
62 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

langerhans cell histiocytosis (lch)